Literature DB >> 3900233

Yeast adhesion in the pathogenesis of endocarditis due to Candida albicans: studies with adherence-negative mutants.

R A Calderone, R L Cihlar, D D Lee, K Hoberg, W M Scheld.   

Abstract

Two spontaneous cerulenin-resistant mutants of Candida albicans, 4918-2 and 4918-10, were unable to adhere in vitro in fibrin-platelet clots. Because in vitro adherence correlates well with colonization of nonbacterial thrombotic endocarditis on traumatized valvular endocardium, 50% infectious dose studies were performed with a rabbit model of endocarditis. Wild-type C. albicans required 10(3.6) +/- 0.12 cfu in comparison with 10(5.73) +/- 0.31 and 10(7.3) +/- 0.21 cfu for mutants 4918-2 and 4918-10, respectively. The relative avirulence of mutant strains in producing endocarditis was not attributed to accelerated clearance of these strains from the bloodstream. In fact, clearance of wild-type and mutant strains was almost identical. In the same animals renal candidiasis was observed with all strains of C. albicans, although the number of cfu per gram of kidney was higher after infection with wild-type C. albicans. Thus, strains of C. albicans with reduced ability to adhere in vitro to a fibrin-platelet matrix are relatively avirulent in the rabbit endocarditis model.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3900233     DOI: 10.1093/infdis/152.4.710

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  21 in total

1.  Adherence of platelets to Candida species in vivo.

Authors:  R Robert; S Nail; A Marot-Leblond; J Cottin; M Miegeville; S Quenouillere; C Mahaza; J M Senet
Journal:  Infect Immun       Date:  2000-02       Impact factor: 3.441

Review 2.  Adherence and receptor relationships of Candida albicans.

Authors:  R A Calderone; P C Braun
Journal:  Microbiol Rev       Date:  1991-03

Review 3.  High-frequency switching in Candida albicans.

Authors:  D R Soll
Journal:  Clin Microbiol Rev       Date:  1992-04       Impact factor: 26.132

4.  Pathogenicity of Candida albicans auxotrophic mutants in experimental infections.

Authors:  D R Kirsch; R R Whitney
Journal:  Infect Immun       Date:  1991-09       Impact factor: 3.441

5.  Mannan composition of the hyphal form of two relatively avirulent mutants of Candida albicans.

Authors:  A Saxena; G E McElhaney-Feser; R L Cihlar
Journal:  Infect Immun       Date:  1990-07       Impact factor: 3.441

6.  Ultrastructure and antigenicity of the unique cell wall pimple of the Candida opaque phenotype.

Authors:  J Anderson; R Mihalik; D R Soll
Journal:  J Bacteriol       Date:  1990-01       Impact factor: 3.490

7.  Susceptibility to thrombin-induced platelet microbicidal protein is associated with increased fluconazole efficacy against experimental endocarditis due to Candida albicans.

Authors:  Michael R Yeaman; Darwin Cheng; Bhavesh Desai; Leon I Kupferwasser; Yan-Qiong Xiong; Kimberly D Gank; John E Edwards; Arnold S Bayer
Journal:  Antimicrob Agents Chemother       Date:  2004-08       Impact factor: 5.191

8.  Characterization of a major cell wall antigen and potential adhesin in three strains of Candida albicans.

Authors:  W Jenq; C L Chen; C C Chang; R F Crang
Journal:  Arch Microbiol       Date:  1994       Impact factor: 2.552

9.  Reduced inhibition of Candida albicans adhesion by saliva from patients receiving oral cancer therapy.

Authors:  M Umazume; E Ueta; T Osaki
Journal:  J Clin Microbiol       Date:  1995-02       Impact factor: 5.948

10.  Characterization of cerulenin-resistant mutants of Candida albicans.

Authors:  K A Hoberg; R L Cihlar; R A Calderone
Journal:  Infect Immun       Date:  1986-01       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.